MarketPeel
Insider Trading Intelligence
LA

Lishan Aklog

LUCD
CHIEF EXECUTIVE OFFICER · LUCID DIAGNOSTICS INC. · CIK 0001665074
FILING MIX · LIFETIME92%/8%
BUYS
11
SELLS
1
TOTAL VALUE
$126.3K
COMPANIES
2
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
3,994,241
AVG SELL PX
$1.18
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Lishan Aklog, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+0.23%-0.13%+0.36%+0.36%
14d1+100.00%+16.12%+2.67%+13.46%+13.46%
30d1+100.00%+14.95%+6.94%+8.02%+8.02%
60d1+0.00%-7.71%+6.49%-14.20%-14.20%
90d1+100.00%+42.29%+8.18%+34.11%+34.11%
180d1+100.00%+75.70%+14.20%+61.50%+61.50%
1y1+0.00%-61.45%+15.42%-76.87%-76.87%
2y1+0.00%-91.59%+2.98%-94.57%-94.57%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LUCD · 3,636,627 shares · as of Feb 20, 2026
0909,1571,818,3142,727,4703,636,6272023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 1 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PAVM
PAVMED INC.
PURCHASEGRANT
Stock grant
350,000357,614Apr 2, 2026Apr 2, 2026View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
2,170,0003,636,627Feb 20, 2026Feb 24, 2026View →
PAVM
PAVMED INC.
PURCHASEGRANT
Stock grant
150,000228,418Sep 30, 2025Oct 2, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
300,0001,466,627Feb 20, 2025Feb 21, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
400,0001,166,627May 7, 2024May 7, 2024View →
PAVM
PAVMED INC.
SALE
Chairman and CEO
79,636$1.18$94.0K176,277Mar 28, 2022Apr 11, 2022View →
PAVM
PAVMED INC.
PURCHASEGRANT
Stock grant
200,000200,000Feb 18, 2022Feb 23, 2022View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
75,00075,000Feb 18, 2022Feb 23, 2022View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
60,000624,400Jan 7, 2022Jan 10, 2022View →
PAVM
PAVMED INC.
PURCHASEGRANT
Stock grant
150,0001,255,913Apr 1, 2021Apr 5, 2021View →
PAVM
PAVMED INC.
PURCHASE
Chairman and CEO
7,500$4.31$32.3K1,105,913Mar 18, 2021Mar 19, 2021View →
PAVM
PAVMED INC.
PURCHASEGRANT
Stock grant
250,0001,098,413Apr 30, 2020May 4, 2020View →
Other insiders · LUCD
Loading peer insiders…
About this filer
CIK 0001665074
ROLE
Chief Executive Officer
PRIMARY
LUCD
COMPANIES
2
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001665074DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback